Paediatric ARVs and formulations

Developed by the IATT in response to procurement and supply challenges resulting from fragmented demand for paediatric ARVs, and has been developing guidance around the selection of optimal products since 2011, this brief is intended for use by programme managers and policy makers and provides formulary selection and procurement guidance for the optimal paediatric ARV dosage forms needed to provide all WHO recommended 1st and 2nd line regimens while simplifying supply chain and easing administration. The brief includes both the Optimal Paediatric ARV formulary as well as the Limited Use list of those formulations that may be needed in special circumstances. As the Optimal Formulary and Limited Use lists are updated on a regular basis, explanation is provided for updates made since 2013.

The IMCI chart booklet is for use by doctors, nurses and other health professionals who see young infants and children less than five years old. It facilitates the use of the IMCI case management process in practice and describes a series of all the case management steps in a form of IMCI charts. 

These charts show the sequence of steps and provide information for performing them. The IMCI chart booklet should be used by all health professionals providing care to sick children to help them apply the IMCI case management guidelines. Health professionals should always use the chart booklet for easy reference. 

The chart booklet is divided into two main parts because clinical signs in sick young infants (up to 2 months) and older children (2 months to 5 years) are somewhat different and because case management procedures also differ between these age groups.